Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Apathy in patients with Parkinson's disease following deep brain stimulation of the subthalamic nucleus.

Hindle Fisher I, Pall HS, Mitchell RD, Kausar J, Cavanna AE.

CNS Spectr. 2016 Jun;21(3):258-64. doi: 10.1017/S1092852916000171. Epub 2016 May 6.

PMID:
27151388
2.

Phenotypic insights into ADCY5-associated disease.

Chang FC, Westenberger A, Dale RC, Smith M, Pall HS, Perez-Dueñas B, Grattan-Smith P, Ouvrier RA, Mahant N, Hanna BC, Hunter M, Lawson JA, Max C, Sachdev R, Meyer E, Crimmins D, Pryor D, Morris JG, Münchau A, Grozeva D, Carss KJ, Raymond L, Kurian MA, Klein C, Fung VS.

Mov Disord. 2016 Jul;31(7):1033-40. doi: 10.1002/mds.26598. Epub 2016 Apr 8.

3.

Theory of mind deficits in Parkinson's disease: a product of executive dysfunction?

Eddy CM, Beck SR, Mitchell IJ, Praamstra P, Pall HS.

Neuropsychology. 2013 Jan;27(1):37-47. doi: 10.1037/a0031302.

PMID:
23356595
4.

Analysis of European case-control studies suggests that common inherited variation in mitochondrial DNA is not involved in susceptibility to amyotrophic lateral sclerosis.

Ingram CJ, Weale ME, Plaster CA, Morrison KE, Goodall EF, Pall HS, Beck M, Jablonka S, Sendtner M, Fisher EM, Bradman N, Kasperavičiūtė D.

Amyotroph Lateral Scler. 2012 Jun;13(4):341-6. doi: 10.3109/17482968.2012.654394. Epub 2012 Mar 13.

PMID:
22409358
5.

Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results.

Harries AM, Kausar J, Roberts SA, Mocroft AP, Hodson JA, Pall HS, Mitchell RD.

J Neurosurg. 2012 Jan;116(1):107-13. doi: 10.3171/2011.7.JNS11319. Epub 2011 Oct 14.

PMID:
21999316
6.

Large-scale pathways-based association study in amyotrophic lateral sclerosis.

Kasperaviciute D, Weale ME, Shianna KV, Banks GT, Simpson CL, Hansen VK, Turner MR, Shaw CE, Al-Chalabi A, Pall HS, Goodall EF, Morrison KE, Orrell RW, Beck M, Jablonka S, Sendtner M, Brockington A, Ince PG, Hartley J, Nixon H, Shaw PJ, Schiavo G, Wood NW, Goldstein DB, Fisher EM.

Brain. 2007 Sep;130(Pt 9):2292-301. Epub 2007 Apr 17.

PMID:
17439985
7.

Genetic studies of GRN and IFT74 in amyotrophic lateral sclerosis.

Xiao S, Sato C, Kawarai T, Goodall EF, Pall HS, Zinman LH, Robertson J, Morrison K, Rogaeva E.

Neurobiol Aging. 2008 Aug;29(8):1279-82. Epub 2007 Mar 23.

PMID:
17383054
8.

Duration of Parkinson disease is associated with an increased propensity for "reinvestment".

Masters RS, Pall HS, MacMahon KM, Eves FF.

Neurorehabil Neural Repair. 2007 Mar-Apr;21(2):123-6.

PMID:
17312087
9.

ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B).

Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM, Morrison KE, Pall HS, Hardiman O, Collinge J, Shaw PJ, Fisher EM; MRC Proteomics in ALS Study; FReJA Consortium.

Neurology. 2006 Sep 26;67(6):1074-7. Epub 2006 Jun 28.

PMID:
16807408
10.

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.

Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P.

Nat Genet. 2003 Aug;34(4):383-94.

PMID:
12847526
11.

Wilson's disease presenting in a family with an apparent dominant history of tremor.

Nicholl DJ, Ferenci P, Polli C, Burdon MB, Pall HS.

J Neurol Neurosurg Psychiatry. 2001 Apr;70(4):514-6.

12.
13.

Arrested progression of the cauda equina syndrome of ankylosing spondylitis after lumboperitoneal shunting.

Larner AJ, Pall HS, Hockley AD.

J Neurol Neurosurg Psychiatry. 1996 Jul;61(1):115-6. No abstract available.

14.

N-methylation of pyridines and Parkinson's disease.

Williams AC, Pall HS, Steventon GB, Green S, Buttrum S, Molloy H, Waring RH.

Adv Neurol. 1993;60:194-6. No abstract available.

PMID:
8420135
15.

Ferritin in the cerebrospinal fluid of patients with Parkinson's disease.

Pall HS, Brailsford S, Williams AC, Lunec J, Blake DR.

J Neurol Neurosurg Psychiatry. 1990 Sep;53(9):803. No abstract available.

16.

Deterioration of Wilson's disease following the start of penicillamine therapy.

Pall HS, Williams AC, Blake DR.

Arch Neurol. 1989 Apr;46(4):359-61. No abstract available.

PMID:
2705894
17.

Intracranial gumma presenting as a cerebral tumour.

Pall HS, Williams AC, Stockley RA.

J R Soc Med. 1988 Oct;81(10):603-4. No abstract available.

18.

Xenobiotic metabolism in motor neuron disease.

Steventon G, Williams AC, Waring RH, Pall HS, Adams D.

Lancet. 1988 Sep 17;2(8612):644-7.

PMID:
2901517
19.

Extrapyramidal reactions to anti-inflammatory drugs.

Wood N, Pall HS, Williams AC, Dieppe C.

J Neurol Neurosurg Psychiatry. 1988 May;51(5):731-2. No abstract available.

21.

Progressive multiple cranial neuropathies presenting as a delayed complication of radiotherapy in infancy.

Pall HS, Nightingale S, Clough CG, Spooner D.

Postgrad Med J. 1988 Apr;64(750):303-5.

22.

Hot-bath epilepsy.

Pall HS, Williams AC.

Postgrad Med J. 1987 Nov;63(745):975-6.

23.

74 year old lady who developed bilateral parkinsonism secondary to an intrinsic cerebral tumour.

Pall HS, Williams A.

J Neurol Neurosurg Psychiatry. 1987 Oct;50(10):1386-7. No abstract available.

24.

Motoneurone disease as manifestation of pesticide toxicity.

Pall HS, Williams AC, Waring R, Elias E.

Lancet. 1987 Sep 19;2(8560):685. No abstract available.

PMID:
2887964
25.

Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines.

Pall HS, Williams AC, Blake DR, Lunec J.

Lancet. 1987 Sep 12;2(8559):596-9.

PMID:
2887888
26.

Movement disorder associated with abnormal copper metabolism and decreased blood antioxidants.

Pall HS, Williams AC, Blake DR, Winyard P, Chirico S, Brailsford S.

J Neurol Neurosurg Psychiatry. 1987 Sep;50(9):1234-5. No abstract available.

27.

Hypomagnesaemia causing myopathy and hypocalcaemia in an alcoholic.

Pall HS, Williams AC, Heath DA, Sheppard M, Wilson R.

Postgrad Med J. 1987 Aug;63(742):665-7.

28.

Raised cerebrospinal-fluid copper concentration in Parkinson's disease.

Pall HS, Williams AC, Blake DR, Lunec J, Gutteridge JM, Hall M, Taylor A.

Lancet. 1987 Aug 1;2(8553):238-41.

PMID:
2886715
29.

Subacute polyradiculopathy with optic and auditory nerve involvement.

Pall HS, Williams AC.

Arch Neurol. 1987 Aug;44(8):885-7.

PMID:
2820362
30.

Extrapyramidal disturbances caused by inappropriate prescribing.

Pall HS, Williams AC.

Br Med J (Clin Res Ed). 1987 Jul 4;295(6589):30-1. No abstract available.

31.

Iron, akathisia, and antipsychotic drugs.

Pall HS, Williams AC, Blake DR.

Lancet. 1986 Dec 20-27;2(8521-22):1469. No abstract available.

PMID:
2878327
32.

Lipid peroxidation and Parkinson's disease.

Pall HS, Williams AC, Blake DR, Winyard P, Lunec J.

Lancet. 1986 Oct 11;2(8511):870-1. No abstract available.

PMID:
2876321
33.

Therapeutic progress--review XX. Drug treatment of Parkinson's disease.

Pall HS, Williams AC, Ramsden DB.

J Clin Hosp Pharm. 1986 Aug;11(4):229-36. Review. No abstract available.

PMID:
3531240
34.

Restless leg syndrome and rheumatoid arthritis.

Reynolds G, Blake DR, Pall HS, Williams A.

Br Med J (Clin Res Ed). 1986 Mar 8;292(6521):659-60. No abstract available.

Supplemental Content

Support Center